N J van Orsouw1, R K Dhanda, Y Elhaji
1Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX 78229, USA. nvorsouw@saci.org
Researchers developed an inexpensive screening system for hereditary breast and ovarian cancer (HBOC) syndrome mutations. This method efficiently detects BRCA1 mutations, potentially lowering diagnostic costs and improving genetic testing accessibility.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: